Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:November 20, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:November 20, 2020Completed
Condition(s):Hermansky Pudlak Syndrome; Interstitial Lung DiseaseLast Updated:December 10, 2019Unknown status
Condition(s):Silicosis; Progressive Massive Fibrosis; Complicated SilicosisLast Updated:January 13, 2022Unknown status
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:April 21, 2017Completed
Condition(s):Coal Workers’ Pneumoconiosis (Complicated)Last Updated:March 21, 2023Completed
Condition(s):Chronic Kidney DiseaseLast Updated:April 27, 2022Recruiting
Condition(s):Rheumatoid Arthritis Interstitial Lung DiseaseLast Updated:August 16, 2022Completed
Condition(s):Restrictive Chronic Lung Allograft Dysfunction; Lung Transplant RejectionLast Updated:June 29, 2023Completed
Condition(s):Acute Lung Injury; PreventionLast Updated:February 22, 2024Recruiting
Condition(s):Pulmonary FibrosisLast Updated:May 3, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.